How to Decide Which Markets Are Worth Entering

Adherent (formerly Compliance & Risks). A person's hands writing in an open notebook with a silver pen, surrounded by a laptop, papers with charts, and a blue mug on a desk.

THIS BLOG WAS WRITTEN BY THE ADHERENT MARKETING TEAM TO INFORM AND ENGAGE. HOWEVER, COMPLEX REGULATORY QUESTIONS REQUIRE SPECIALIST KNOWLEDGE. TO GET ACCURATE, EXPERT ANSWERS, PLEASE CLICK ASK AN EXPERT.

Quick Answer

Market selection is a compliance decision as much as a commercial one. Five questions decide it: what does your current and planned market picture actually look like, what business outcome do you want in each market, which products legally qualify there, where does your existing compliance work transfer, and what does compliant entry cost in full. Answer those before commercial signs off, and expansion becomes a priced decision rather than a discovered one.

Key Takeaways
What does a complete picture of your current and planned markets look like?
How do you define the business outcome you want in each market?
How do you decide which products belong in which markets?
How do you identify markets you can enter with low investment and high opportunity?
What compliance cost should you weigh before committing to a market?
FAQ

Key Takeaways

Market selection is a compliance decision as much as a commercial one. The cost of compliant entry should be known before the commitment is made, not after.
Start with a complete, current picture of where you already sell and plan to sell, mapped by product and jurisdiction, before scoring anything new.
Define a specific business outcome per market so you can weigh it against entry cost, rather than chasing volume.
Match products to markets by regulatory applicability. The same product can be low-cost in one jurisdiction and effectively prohibited in another.
The cheapest high-opportunity markets are usually the ones where your existing compliance work already transfers.
Price registration, testing, labelling, ongoing monitoring, and time-to-market delay into the go or no-go decision.

What does a complete picture of your current and planned markets look like?

A complete market picture is a single view of every jurisdiction where you currently sell and plan to sell, mapped against each product line and the regulatory obligations attached to that pairing. It shows more than geography and revenue. It shows which requirements you already meet, where you carry gaps, and how much compliance effort each market consumes today.

Market selection starts with knowing what you already own, because your current footprint is the asset that makes the next market cheap or expensive.

The picture has three layers. Geography is the easy one. Product-to-market mapping is harder, because catalogues rarely reflect what is actually sold where. The regulatory obligations attached to each product and market pairing are hardest, and they are the layer that decides cost.

Three blind spots recur. Distributor and gray-market sales into jurisdictions you never formally entered. Markets where you are technically non-compliant and have not been challenged yet. And requirements you meet by accident rather than by design, which will not survive a product change.

The deeper problem is usually that commercial and compliance hold different maps of the same reality. Commercial knows where revenue comes from. Compliance knows where obligations attach. Neither map is complete on its own, and expansion decisions get made from whichever one is in the room.

Building the regulatory universe underneath that picture is what makes it durable. Global market access covers how compliance teams turn that view into an enabler for international growth rather than a gate on it.

How do you define the business outcome you want in each market?

Define a specific, measurable outcome per market before assessing feasibility: target revenue, required margin, strategic regional access, or defensive positioning. The outcome sets the bar that entry cost has to clear. A market chased for size alone frequently fails to justify its regulatory burden.

The outcome types worth distinguishing are revenue growth, margin, strategic access where a market serves as a regional hub, competitive defence, and supply-chain proximity. They justify very different levels of compliance investment.

“It is a big market” is not an outcome. Large markets often carry the heaviest regulatory load precisely because they are large and well policed. Size raises both the opportunity and the entry cost, and only one of those usually makes it into the business case.

Set a threshold the outcome has to beat once entry cost is subtracted. Without a threshold there is no decision, only a preference.

Time horizon changes the answer. A market entered for quick revenue justifies a very different compliance investment than one entered to hold a position for a decade. Same regulation, same cost, different verdict.

How do you decide which products belong in which markets?

Decide product and market fit by regulatory applicability, not by demand alone. The same product can be inexpensive to sell in one jurisdiction and effectively prohibited in another because of chemical restrictions, labelling rules, safety standards, cybersecurity requirements, or circular-economy obligations.

The first question is whether the product legally qualifies for the market as currently designed. Demand is irrelevant until that is answered.

Product-level variation matters more than category-level assumption. A variant that passes in the EU may need reformulation, relabelling, or a different certification route for the US, Asia, or Africa, and the difference is often a single component or claim. Environmental requirements by product category is a useful starting map for where those differences cluster.

The requirement categories that most often gate a product are chemicals restrictions such as REACH and the widening set of state-level PFAS rules, labelling and packaging, safety standards, cybersecurity, and ESG or circular-economy obligations. Adherent’s snapshot of US state-level PFAS developments shows how quickly a single substance class can fragment a market that looks unified.

Once applicability is clear, there are three honest options: adapt the product, skip the market, or enter with a limited product range. The third is underused. Entering with the two variants that already qualify is often better than delaying entry until the whole range does.

This is where scale becomes the constraint. Adherent’s figures put the average at 1,002 regulations for a new product entering a single market. Assessing applicability at that volume by hand is what makes market evaluation slow, which is why applicability assessment is the step most worth automating.

How do you identify markets you can enter with low investment and high opportunity?

The best low-investment, high-opportunity markets are the ones where your existing compliance work transfers. Jurisdictions that recognise standards you already meet, share requirement frameworks with markets you serve, or accept evidence you have already produced. Reused compliance effort, not new spend, is what makes entry cheap.

Start from what you already hold. Existing test reports, certifications, and evidence packages carry over more often than teams assume, and nobody audits the portfolio for reuse potential unless someone asks.

Requirement overlap between jurisdictions is the mechanism. Mutual recognition agreements and harmonised standards create genuine shortcuts, and mapping where frameworks converge is how you find them. A regulatory crosswalk across overlapping frameworks is the practical version of this exercise.

Score candidates on a simple matrix: opportunity against incremental compliance effort, where incremental means what you would have to do that you have not already done.

Watch divergence trends as well as current state. A market that is cheap to enter today can become expensive if its requirements are actively diverging from the frameworks you already meet. That is a monitoring question, and it belongs in the entry decision rather than in a review two years later.

What compliance cost should you weigh before committing to a market?

Weigh the full cost of compliant entry: registration and conformity-assessment fees, product testing and certification, labelling and documentation changes, in-market representation, and ongoing monitoring and renewals. Then add time-to-market delay, which is frequently the largest hidden cost of all.

One-time entry costs are the visible ones: registration, testing, certification, product or label adaptation, and legal representation.

Recurring costs are the ones that decide long-term viability: continuous regulatory monitoring, renewals, and any sustainability or ESG reporting the market imposes. Adherent tracks an average of 217 regulatory changes per month globally, and every market you hold adds to the share of that flow you have to triage.

The cost of time is routinely left out. A certification route that pushes revenue out by two quarters changes the return profile of the entry, and it is knowable in advance far more often than teams treat it as knowable.

The cost of getting it wrong belongs in the same calculation: recall, market withdrawal, and penalty exposure. The real cost of non-compliance sets out how market-access risk compounds when entry is committed before the number exists.

The decision rule is worth stating plainly. No market is worth entering until its compliance cost of entry is quantified and beaten by the business outcome you want there. Run these five questions before commercial signs off, and expansion becomes a priced decision instead of a discovered one.

FAQ

Should compliance have a veto on market entry?
Not a veto, a price. Compliance’s job is to make the cost of compliant entry visible and defensible before the commitment. If commercial still wants the market at that price, that is a legitimate decision made with the facts present.
How early should compliance be involved in expansion planning?
Before the shortlist is set. Involving compliance after markets are chosen turns the function into a blocker, because the only remaining options are delay or accept risk.
What is the most commonly missed entry cost?
Ongoing monitoring and renewals. Teams price the entry and not the tenancy, so markets look cheaper at the decision point than they turn out to be in year three.
Can we enter a market with only part of our range?
Yes, and it is often the better move. Entering with the products that already qualify captures revenue while the rest of the range is adapted, rather than holding the whole entry to the pace of the hardest product.
How do we compare markets with very different regulatory systems?
Compare incremental effort rather than absolute complexity. A heavily regulated market where you already meet most requirements can be cheaper to enter than a lightly regulated one where nothing you hold transfers.